ES2175328T3 - Piperidonas como antagonistas de la taquiquinina. - Google Patents

Piperidonas como antagonistas de la taquiquinina.

Info

Publication number
ES2175328T3
ES2175328T3 ES97901034T ES97901034T ES2175328T3 ES 2175328 T3 ES2175328 T3 ES 2175328T3 ES 97901034 T ES97901034 T ES 97901034T ES 97901034 T ES97901034 T ES 97901034T ES 2175328 T3 ES2175328 T3 ES 2175328T3
Authority
ES
Spain
Prior art keywords
compounds
antagonists
preparation
taquiquinina
piperidonas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97901034T
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Allan Patrick Marchington
Donald Stuart Middleton
Sandra Dora Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research and Development Co NV SA filed Critical Pfizer Research and Development Co NV SA
Application granted granted Critical
Publication of ES2175328T3 publication Critical patent/ES2175328T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

LA PRESENTE INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I) Y LAS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN LA QUE X ES UN ENLACE DIRECTO O ALQUILENO C1 C 4 Y R ES CICLOALQUILO C 3 - C 7 OPCIO NALMENTE SUSTITUIDO CON 1 O 2 SUSTITUYENTES INDEPENDIENTEMENTE SELECCIONADOS ENTRE FLUORO Y CICLOALQUILO C 3 - C 7 , CON LA CONDICION DE QUE X NO ES METILENO CUANDO R ES CICLOPROPILO, JUNTO CON LOS PROCEDIMIENTOS PARA LA PREPARACION DE DICHOS COMPUESTOS, INTERMEDIOS UTILIZADOS EN LA PREPARACION DE DICHOS COMPUESTOS, COMPOSICIONES QUE CONTIENEN DICHOS COMPUESTOS Y USOS DE, DICHOS COMPUESTOS. ESTOS COMPUESTOS SON UTILES COMO ANTAGONISTAS DE LA TAQUIQUININA.
ES97901034T 1996-01-22 1997-01-09 Piperidonas como antagonistas de la taquiquinina. Expired - Lifetime ES2175328T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9601202.6A GB9601202D0 (en) 1996-01-22 1996-01-22 Piperidones

Publications (1)

Publication Number Publication Date
ES2175328T3 true ES2175328T3 (es) 2002-11-16

Family

ID=10787341

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97901034T Expired - Lifetime ES2175328T3 (es) 1996-01-22 1997-01-09 Piperidonas como antagonistas de la taquiquinina.

Country Status (16)

Country Link
US (1) US6262075B1 (es)
EP (1) EP0888337B1 (es)
JP (1) JP3140063B2 (es)
AT (1) ATE218563T1 (es)
AU (1) AU1442297A (es)
CA (1) CA2240964C (es)
CO (1) CO4560412A1 (es)
DE (1) DE69713075T2 (es)
DK (1) DK0888337T3 (es)
ES (1) ES2175328T3 (es)
GB (1) GB9601202D0 (es)
HR (1) HRP970040A2 (es)
MA (1) MA26418A1 (es)
PT (1) PT888337E (es)
TN (1) TNSN97014A1 (es)
WO (1) WO1997027185A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
AU1089599A (en) * 1997-10-15 1999-05-03 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
ATE297906T1 (de) 1997-12-04 2005-07-15 Sankyo Co Alicyclische acylierte heterocyclenderivate
GB9812037D0 (en) * 1998-06-04 1998-07-29 Pfizer Ltd Piperidones
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB0005366D0 (en) * 2000-03-06 2000-04-26 Xenova Ltd Pharmaceutical compounds
TW200508221A (en) * 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
DE10336274A1 (de) * 2003-08-07 2005-03-10 Honeywell Specialty Chemicals Verfahren zur Herstellung von geminalen Difluoralkanen
WO2006137790A1 (en) * 2005-06-23 2006-12-28 Astrazeneca Ab New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
JP2008546768A (ja) * 2005-06-23 2008-12-25 アストラゼネカ・アクチエボラーグ 胃腸疾患を治療するためのニューロキニン受容体アンタゴニストとしての新規なアゼチジン誘導体
AR056087A1 (es) * 2005-09-29 2007-09-19 Astrazeneca Ab Derivados de azetidina como antagonistas de receptores de neuroquina nk
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
TW201026666A (en) * 2008-12-16 2010-07-16 Astrazeneca Ab Quaternary piperidine derivatives and uses thereof
US8946434B2 (en) 2010-07-16 2015-02-03 N30 Pharmaceuticals, Inc. Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
DE69713075T2 (de) 2003-02-27
GB9601202D0 (en) 1996-03-20
WO1997027185A1 (en) 1997-07-31
CA2240964C (en) 2002-06-25
AU1442297A (en) 1997-08-20
CA2240964A1 (en) 1997-07-31
ATE218563T1 (de) 2002-06-15
DK0888337T3 (da) 2002-07-01
PT888337E (pt) 2002-09-30
MA26418A1 (fr) 2004-12-20
JP3140063B2 (ja) 2001-03-05
DE69713075D1 (de) 2002-07-11
EP0888337B1 (en) 2002-06-05
TNSN97014A1 (fr) 2005-03-15
HRP970040A2 (en) 1998-06-30
CO4560412A1 (es) 1998-02-10
JPH11505271A (ja) 1999-05-18
US6262075B1 (en) 2001-07-17
EP0888337A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
ES2175328T3 (es) Piperidonas como antagonistas de la taquiquinina.
ES2179318T3 (es) Derivados de acido cinamico y su uso como antagonistas de integrina.
ES8602763A1 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
NL300298I1 (nl) Nieuwe 3-piperidinyl-1,2-benzisoxazolen
FI955258A0 (fi) Takykiniiniantagonisteina käyttökelpoisia substituoituja pyrrolidiini-3-yl-alkyyli-piperidiineja
ES2137998T3 (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
ATE300541T1 (de) Pyrazolopyridinderivate
GB1478248A (en) Substituted 3-chloro-2-oxazolidinones and germicidal compo sitions thereof
DE69613457T2 (de) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
CA2109435A1 (en) Compositions of N-(Phosphonoacetyl)-L-Aspartic Acid and Methods of Their Use as Broad Spectrum Antivirals
PT962457E (pt) Piperidonas como antagonistas de taquicinina
DE3573119D1 (en) 8-alkylthio-2-piperazino-pyrimidoû5,4-d¨pyrimidines, their preparation and medicaments containing them
ATE282608T1 (de) Chinoxalindionen
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
UY26972A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
ECSP972007A (es) Piperidonas
SE9304065D0 (sv) New compound

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 888337

Country of ref document: ES